There are more non-Americans with psoriasis than Americans. OWCP is playing it very smart, as usual. IRB trials in Israel are faster and less expensive, and accepted, I believe, in Europe, Canada, Asia and South America. Should also be accepted by US States that have MMJ laws on the book, I believe.

Revenue from the psoriasis cream worldwide will pay for FDA clinical trials eventually.